Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonization factor antigen CS3 (CS3) is a critical surface-exposed fimbrial adhesin found on Enterotoxigenic Escherichia coli (ETEC), which is a leading cause of traveler's diarrhea and significant childhood morbidity in developing nations (PubMed: 29158424). Unlike many other ETEC fimbriae that form rigid, rod-like structures, CS3 consists of thin, flexible fibrillae that facilitate the initial attachment of the bacteria to the human intestinal epithelium (PubMed: 25691586). This adhesion is a mandatory prerequisite for successful colonization and the subsequent delivery of heat-labile (LT) and heat-stable (ST) toxins that trigger diarrheal symptoms (UniProt: P0CK95). Because of its high prevalence among clinical ETEC isolates and its essential role in pathogenesis, CS3 is a primary target for broad-spectrum ETEC vaccine development (PubMed: 31606201). Current therapeutic strategies, such as the oral inactivated vaccine ETVAX, focus on eliciting a robust mucosal immune response, specifically secretory IgA antibodies that neutralize the adhesin. By blocking CS3-mediated attachment, these interventions effectively prevent bacterial colonization and the onset of clinical disease.
Immune exclusion via the induction of mucosal secretory IgA antibodies that bind to the CS3 adhesin, thereby preventing bacterial attachment to host intestinal epithelial cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonization factor antigen CS3 fimbrial adhesin (CS3).